@article{ref1,
title="Association of baclofen with falls and fractures in patients with CKD",
journal="American journal of kidney diseases",
year="2021",
author="Muanda, Flory T. and Blake, Peter G. and Weir, Matthew A. and Bathini, Lavanya and Chauvin, Kianna and Dixon, Stephanie N. and McArthur, Eric and Sontrop, Jessica M. and Moist, Louise and Kim, Richard B. and Garg, Amit X.",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="Baclofen is a popular muscle relaxant that is eliminated primarily unchanged in the urine. We recently reported a higher risk of encephalopathy in a cohort of 15,942 older adults with chronic kidney disease (CKD) who started baclofen at ≥20 mg/day vs. <20 mg/day; a higher risk was also observed in all baclofen users vs. non-users. In another study of patients receiving dialysis, 1 in 14 were hospitalized with encephalopathy within 3 days of starting baclofen...<p /> <p>Language: en</p>",
language="en",
issn="1523-6838",
doi="10.1053/j.ajkd.2020.12.017",
url="http://dx.doi.org/10.1053/j.ajkd.2020.12.017"
}